Vascular Therapies
Cresskill
About Vascular Therapies
Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring a vascular access to support hemodialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications. The company was founded in 2001 and headquartered in Cresskill, New Jersey.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $90.0M
- Last round: Series Unknown (Mar 2022)
- Website: vasculartx.com
- Phone: (201) 266-8310
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vascular-therapies-9012 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.